Blind Loop Syndrome (Bacterial Overgrowth Syndrome)

A malabsorption syndrome that is associated with a blind loop in the upper SMALL INTESTINE that is characterized by the lack of peristaltic movement, stasis of INTESTINAL CONTENTS, and the overgrowth of BACTERIA. Such bacterial overgrowth interferes with BILE SALTS action, FATTY ACIDS processing, MICROVILLI integrity, and the ABSORPTION of nutrients such as VITAMIN B12 and FOLIC ACID.
Also Known As:
Bacterial Overgrowth Syndrome; Stagnant Loop Syndrome; Loop Syndrome, Stagnant; Loop Syndromes, Stagnant; Stagnant Loop Syndromes; Syndrome, Bacterial Overgrowth; Syndrome, Blind Loop; Syndrome, Stagnant Loop; Syndromes, Stagnant Loop
Networked: 76 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Lactose Intolerance (Intolerance, Lactose)
2. Peptic Ulcer (Peptic Ulcers)
3. Gastroesophageal Reflux (GERD)
4. Chronic Pancreatitis
5. Steatorrhea


1. Kharitonova, L A: 1 article (01/2015)
2. Bogomaz, L V: 1 article (01/2015)
3. Zaprudnov, A M: 1 article (01/2015)
4. Grigoriev, K I: 1 article (01/2015)
5. Tokumasu, Naoko: 1 article (09/2013)
6. Akira, Kazuki: 1 article (09/2013)
7. Tando, Yusuke: 1 article (09/2013)
8. Nakamura, Teruo: 1 article (09/2013)
9. Mitome, Hidemichi: 1 article (09/2013)
10. Carubbi, Francesco: 1 article (05/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Blind Loop Syndrome:
1. IndicanIBA
2. HydrogenIBA
3. Phenol (Carbolic Acid)FDA Link
4. FructoseIBA
5. 4-cresol (p-cresol)IBA
6. Bile Acids and Salts (Bile Acids)IBA
7. Intrinsic FactorFDA Link
8. Xylose (D-Xylose)FDA Link
9. Urea (Carbamide)FDA LinkGeneric
10. CholesterolIBA

Therapies and Procedures

1. Cholecystectomy
2. Jejunoileal Bypass
3. Ileostomy
4. Enzyme Replacement Therapy
5. Colonic Pouches (S Pouch)